Physician Assistant · Ann Arbor, MI
NPI
1164946257
Since 2017
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 E Medical Center Dr, B1 Floor Cancer Center Recp B
Ann Arbor, MI, 48109
Phone (734) 647-8901
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
416 services
Medicare patients, 2024
161
Average age 72
Drug cost, 2024
$11.4M
1,412 prescriptions
Company payments, 2025
$1,128
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristen M Kindervater was code 99214 (office e&m - established), 162 times for 101 patients. In total Kristen M Kindervater billed 416 services in 7 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 162 | 101 | $53.50 | $8,666 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 103 | 73 | $10.84 | $1,117 |
| 99443 Telephone Services | Office | 69 | 46 | $53.32 | $3,679 |
| 99215 Office E&M - Established | Facility | 55 | 32 | $87.36 | $4,805 |
| 38222 Other Organ Systems | Facility | 19 | 17 | $50.96 | $968 |
By year: 2022 $7,584 for 130 services; 2023 $21K for 293 services; 2024 $20K for 416 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristen M Kindervater prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 376 prescriptions and refills. In total Kristen M Kindervater wrote 1,412 Medicare prescriptions that cost $11.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 376 | 376 | 44 | $5.8M |
| Hydroxyurea Generic | 356 | 798 | 101 | $14K |
| Ojjaara Momelotinib Dihydrochloride | 71 | 71 | 13 | $1.9M |
| Imatinib Mesylate Generic | 71 | 71 | Under 11 | $23K |
| Bosulif Bosutinib | 65 | 73 | Under 11 | $660K |
| Pegasys Peginterferon Alfa-2a | 49 | 49 | Under 11 | $134K |
| Besremi Ropeginterferon Alfa-2b-Njft | 40 | 40 | Under 11 | $581K |
| Anagrelide Hcl Generic | 39 | 89 | Under 11 | $14K |
| Scemblix Asciminib Hydrochloride | 33 | 35 | Under 11 | $902K |
| Acyclovir Generic | 30 | 42 | Under 11 | $521 |
| Allopurinol Generic | 22 | 65 | Under 11 | $363 |
| Iclusig Ponatinib Hcl | 20 | 20 | Under 11 | $246K |
| Sprycel Dasatinib | 18 | 18 | Under 11 | $102K |
| Tasigna Nilotinib Hcl | 18 | 22 | Under 11 | $112K |
| Prochlorperazine Maleate Generic | 13 | 13 | Under 11 | $448 |
Brand drugs: 765 claims; generic drugs: 647 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristen M Kindervater $1,128 ($1,128 in general payments such as food, travel and fees) from 1 company. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $1,128.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $1,128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.